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. In vitro fluorescent staining of complexes 14, 15 and 16 on CAA patient. Figure S5 . 
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1 H NMR (CDCl 3 ) spectrum of 2,2'-(7-(3-((2-(4-(dimethylamino)phenyl)benzo[d]thiazol- 6-yl)oxy)propyl)-1,4,7-triazonane-1,4-diyl)diacetic acid (7). Figure S6. MS spectrum of 2,2'-(7-(3-((2-(4-(dimethylamino)phenyl)benzo[d]thiazol-6- yl)oxy)propyl)-1,4,7-triazonane-1,4-diyl)diacetic acid (7). S6 Figure S7. 1 H NMR (CDCl 3 ) spectrum of 2,2'-(7-(5-((2-(4-(methylamino)phenyl)benzo[d]thiazol-6- yl)oxy)pentyl)-1,4,7-triazonane-1,4-diyl)diacetic acid (8).
